KRAS and colorectal carcinoma: Notably, our results indicated that the combination of all four markers did not significantly enhance diagnostic performance compared to the combination of KRAS, M3, and Methylation alone, suggesting that the combination of KRAS, M3, and Methylation might be the most effective strategy for CRC diagnosis, especially for early CRC patients.